Are you Dr. Krauss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3101 Telegraph Ave
2ND floor
Berkeley, CA 94705Phone+1 510-665-0500Fax+1 510-665-3177
Summary
- Dr. Ronald Krauss, MD is an endocrinologist in Berkeley, California. He is currently licensed to practice medicine in California. He is affiliated with University of California San Francisco Medical Center at Mount Zion and Kaiser Permanente San Francisco Medical Center.
Education & Training
- Boston University Medical CenterResidency, Internal Medicine, 1968 - 1970
- Harvard Medical SchoolClass of 1968
Certifications & Licensure
- CA State Medical License 1973 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1988
Clinical Trials
- Cholesterol and Pharmacogenetic Study Start of enrollment: 2002 Mar 01
- Dietary Protein and Insulin Sensitivity Study Start of enrollment: 2007 Feb 01
- The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1371 citationsDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel
Current Opinion in Cardiology. 2006-01-01 - 2767 citationsBiological, clinical and population relevance of 95 loci for blood lipidsTanya M. Teslovich, Kiran Musunuru, Albert V. Smith, Andrew C. Edmondson, Ioannis M. Stylianou
Nature. 2010-08-05 - 240 citationsHigh-density lipoproteins: A consensus statement from the National Lipid AssociationPeter P. Toth, Philip J. Barter, Robert S. Rosenson, William E. Boden, M. John Chapman
Journal of Clinical Lipidology. 2013-09-01
Press Mentions
- Supplements Warning: The ‘Potentially Harmful’ Vitamins That May Cause High CholesterolJanuary 8th, 2022
- Curiosity Prevails: A Conversation with Robert H. Eckel, MDSeptember 12th, 2021
- Is Chicken Healthier Than Beef?June 18th, 2019
- Join now to see all
Grant Support
- Genetic Etiology Of Cancer Drug ResponseNational Cancer Institute2012
- Saturated Fat And Protein Effects On Atherogenic DyslipidemiaNational Heart, Lung, And Blood Institute2011
- Pharmacogenomics And Risk Of Cardiovascular DiseaseNational Heart, Lung, And Blood Institute2010–2011
- Genetic And Molecular Approaches To Cardiovascular DiseaseNational Heart, Lung, And Blood Institute2009–2011
- Effects Of Resistant Starch On Lipid And Glucose Metabolism In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Hmg-Coa Reductase Alternative Splicing And LDL Response To StatinNational Heart, Lung, And Blood Institute2009–2010
- Pharmacogenomics And Risk Of Cardiovascular DiseaseNational Heart, Lung, And Blood Institute2005–2009
- Core--Lipids And Chronic DiseasesNational Center On Minority Health And Health Disparities2003–2007
- The Effects Of Normalizing Adiposity On Atherogenic Lipoprogeins In SubjectsNational Center For Research Resources2005
- Comparative Genomic Analysis Of Cardiovascular Gene RegulationNational Center For Research Resources2003–2004
- Pharmacogenetics Network For Cardiovascular Risk TherapyNational Heart, Lung, And Blood Institute2002–2004
- Comparative Genomic Analysis Of Cardiovascular Gene ReguNational Heart, Lung, And Blood Institute2000–2003
- Pharmacogenetics Network For Cardiovascular Risk TherapyNational Heart, Lung, And Blood Institute2001
- Lipoproteins And Atherogenesis In Transgenic AnimalsNational Heart, Lung, And Blood Institute1997–2001
- Atherogenic Lipoprotein Subspecies In Transgenic MiceNational Heart, Lung, And Blood Institute1997–2001
- Metabolic And Genetic Origins Of Lipoprotein SubclassesNational Heart, Lung, And Blood Institute1992–1997
- Characterization Of Lipoprotein Subclass PhenotypesNational Heart, Lung, And Blood Institute1991–1996
- Plasma Lipoproteins In Coronary Artery DiseaseNational Heart, Lung, And Blood Institute1985–1992
- Metabolic &Genetic Origins Of Lipoprotein SubclassesNational Heart, Lung, And Blood Institute1991
- Lipoprotein Subclasses Structure, Origin And MetabolismNational Heart, Lung, And Blood Institute1990
- Lipoprotein Subclasses And LDL Subspecies Structure And MetabolismNational Heart, Lung, And Blood Institute1986–1990
- Effects Of Hormones, Lipolytic Enzyme And DietsNational Heart, Lung, And Blood Institute1985